China's Health Supplements Market Hits CN¥ 115B Online
By Jotham Lim
5 min read
Executive Summary#
China's online health supplements market reached CN¥ 115.45 billion in combined sales across Taobao/Tmall, JD.com, and Douyin in 2023, growing +24.6% year-on-year (YoY). Douyin emerged as the fastest-growing platform at +100.4% YoY, surpassing JD.com for the first time, while the broader market remains significantly underpenetrated compared to developed economies --- China's per capita supplement spending of US$ 38 trails the United States (US$ 194) by roughly five-fold. This structural gap, combined with rising health consciousness and an aging population, positions the market for sustained double-digit expansion.
Market Size and Growth: A CN¥ 328B Opportunity#
China's total health supplement market is projected to reach CN¥ 328.3 billion by end of 2023, having grown at a 12.4% Compound Annual Growth Rate (CAGR) from CN¥ 144.6 billion in 2016. The market has more than doubled in absolute terms over seven years, driven by deepening health consciousness, rising disposable incomes, and expanding e-commerce channels.
The global comparison underscores the scale of the opportunity ahead. At US$ 38 per capita annually, China's health supplement spending trails Australia (US$ 205) by more than five-fold, the United States (US$ 194) by roughly five-fold, Japan (US$ 138) by over three-fold, and Canada (US$ 110) by nearly three-fold. Western Europe's US$ 56 serves as a useful mid-point benchmark, suggesting that China could reach similar per capita levels within five to seven years as income growth and health education continue to advance.
Penetration rates reinforce this growth thesis. Across all age groups, China trails the United States by 20 to 50 percentage points. The widest proportional gap appears in the 35-44 age cohort --- 11% penetration in China versus 51% in the US --- representing the highest-potential target demographic for market expansion given its peak earning power and increasing health awareness. The convergence gap represents a CN¥ 200-400 billion incremental opportunity as Chinese consumer spending patterns increasingly mirror those of developed markets.
Platform Breakdown: Douyin Doubles, Taobao Holds Ground#
The online health supplements landscape underwent a decisive structural shift in 2023. Total online sales across the three major platforms reached CN¥ 115.45 billion (+24.6% YoY), with sales volume hitting 610 million units (+28.4% YoY) and average selling price declining -3.0% to CN¥ 194.2 per unit --- suggesting that volume growth and new consumer acquisition are outpacing premiumization trends.
Douyin achieves +100.4% YoY growth, surpassing JD.com in health supplement sales
Brand Landscape: International Dominance, Domestic Gains#
International brands from the United States, Australia, Japan, and Germany collectively hold nearly 70% of the Taobao ecosystem market share. US-origin brands lead at 32.0%, though their share slipped from 35.5% in 2022. Meanwhile, Mainland China brands grew from 31.0% to 32.2%, narrowing the gap to less than one percentage point.
Among the top ten brands on Taobao/Tmall, Swisse maintains its leading position through a comprehensive portfolio spanning vitamins, herbal supplements, and mineral products. By-Health (汤臣倍健), as the benchmark domestic dietary supplement brand, consistently ranks in the top three. Both leading brands share a common strength: strong presence across multiple key functional categories rather than single-category specialization.
Market concentration is declining. The CR5 fell from 16.2% in 2022 to 14.6% in 2023, reflecting a market that is becoming more fragmented as new entrants challenge established players. The number of active brands on Taobao's ecosystem grew from approximately 7,000 in 2020 to roughly 12,000 by late 2023, a +73% increase. This intensifying competition provides consumers with greater choice while creating margin pressure for incumbent brands and entry opportunities for focused challengers.
Functional Sub-Segments: Where Growth Is Concentrated#
Cardiovascular health and bone health drive growth while oral beauty declines
Key Takeaways#
- Structural growth, not cyclical: China's health supplement market is projected at CN¥ 328.3 billion, with per capita spending at US$ 38 versus US$ 194 in the US, indicating years of convergence-driven expansion ahead.
- Douyin is the new growth engine: At +100.4% YoY, Douyin's content-commerce model has fundamentally changed how consumers discover and purchase supplements, making multi-platform distribution essential.
- Domestic brands are closing the gap: Chinese brands grew to 32.2% Taobao market share, nearly matching US brands at 32.0%, as By-Health and others invest in R&D and regulatory certifications.
- Cardiovascular and bone health are the segments to watch: These two categories combine billion-scale revenue with strong double-digit growth, displacing oral beauty as the market's center of gravity.
- Market fragmentation creates entry windows: With CR5 declining to 14.6% and active brands exceeding 12,000, focused challengers can establish positions in underserved functional niches.
About the Data#
This analysis is based on Moojing Market Intelligence data covering China's major e-commerce platforms including Taobao (淘宝), Tmall (天猫), JD.com (京东), and Douyin (抖音) for the period Q2 2024. Total market projections incorporate third-party data from Euromonitor and iiMedia Data Center.
Download the Full Report#
This content adheres to Moojing's editorial standards .
Frequently Asked Questions
CN¥ 115.45 billion in 2023 across the major e-commerce channels, growing +24.6% year on year on 610 million units (+28.4%). Average selling price moved -3.0% to CN¥ 194.2, which says the growth is coming from new consumers entering the category rather than from existing ones trading up. The total market including offline is projected at CN¥ 328.3 billion by the end of 2023, having compounded at 12.4% a year from CN¥ 144.6 billion in 2016 — more than doubling in absolute terms over seven years.
Substantially, and the gap is the investment case. China's per capita supplement spending is US$ 38, against Australia at US$ 205, the United States at US$ 194, Japan at US$ 138 and Canada at US$ 110. Western Europe's US$ 56 is the more useful benchmark, and it is reachable within five to seven years on current income and health-education trends. Penetration tells the same story: China trails the United States by 20 to 50 percentage points across age groups, with the widest proportional gap in the 35-44 cohort — 11% against 51%. That cohort pairs peak earning power with rising health awareness, which makes it the highest-potential target.
Fragmenting, clearly. The combined share of the five largest brands moved from 16.2% in 2022 to 14.6% in 2023, while the number of active brands in the largest marketplace ecosystem grew from roughly 7,000 in 2020 to about 12,000 by late 2023 — a +73% increase. That combination puts margin pressure on incumbents and opens entry windows for focused challengers, particularly in functional niches a broad-line portfolio serves only generically. Origin share is converging too: US-origin brands moved from 35.5% in 2022 to 32.0%, while mainland Chinese brands went from 31.0% to 32.2%, closing the gap to under a percentage point.
Cardiovascular health and bone health are where scale and growth meet — both combine billion-scale revenue with strong double-digit growth, and together they have displaced oral beauty as the category's centre of gravity. The strategic reading is that the two strongest brands here share one trait: presence across several key functional categories rather than specialisation in one. For a challenger without that breadth the opposite approach applies — own a single underserved functional niche completely, because the fragmenting share structure means a defensible narrow position is now available in a way it was not a few years ago.
